| EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent N Mottet, J Bellmunt, M Bolla, E Briers, MG Cumberbatch, M De Santis, ... European urology 71 (4), 618-629, 2017 | 3619 | 2017 |
| EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer—2020 update. Part 1: screening, diagnosis, and local treatment with curative intent N Mottet, RCN van den Bergh, E Briers, T Van den Broeck, ... European urology 79 (2), 243-262, 2021 | 2073 | 2021 |
| EAU-ESTRO-SIOG guidelines on prostate cancer. Part II: treatment of relapsing, metastatic, and castration-resistant prostate cancer P Cornford, J Bellmunt, M Bolla, E Briers, M De Santis, T Gross, AM Henry, ... European urology 71 (4), 630-642, 2017 | 1547 | 2017 |
| Systematic review and meta-analysis of studies reporting urinary continence recovery after robot-assisted radical prostatectomy V Ficarra, G Novara, RC Rosen, W Artibani, PR Carroll, A Costello, ... European urology 62 (3), 405-417, 2012 | 1266 | 2012 |
| Systematic review and meta-analysis of studies reporting potency rates after robot-assisted radical prostatectomy V Ficarra, G Novara, TE Ahlering, A Costello, JA Eastham, M Graefen, ... European urology 62 (3), 418-430, 2012 | 842 | 2012 |
| EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer. Part II—2020 update: treatment of relapsing and metastatic prostate cancer P Cornford, RCN van den Bergh, E Briers, T Van den Broeck, ... European urology 79 (2), 263-282, 2021 | 784 | 2021 |
| Urine markers for bladder cancer surveillance: a systematic review BWG Van Rhijn, HG Van der Poel, TH van Der Kwast European urology 47 (6), 736-748, 2005 | 687 | 2005 |
| Guidelines on prostate cancer N Mottet, J Bellmunt, E Briers, RCN Van den Bergh, M Bolla, ... European Association of Urology 56, e137, 2015 | 584 | 2015 |
| A phase I trial of CV706, a replication-competent, PSA selective oncolytic adenovirus, for the treatment of locally recurrent prostate cancer following radiation therapy TL DeWeese, H van der Poel, S Li, B Mikhak, R Drew, M Goemann, ... Cancer research 61 (20), 7464-7472, 2001 | 529 | 2001 |
| The benefits and harms of different extents of lymph node dissection during radical prostatectomy for prostate cancer: a systematic review N Fossati, PPM Willemse, T Van den Broeck, RCN van den Bergh, ... European urology 72 (1), 84-109, 2017 | 479 | 2017 |
| Prognostic value of biochemical recurrence following treatment with curative intent for prostate cancer: a systematic review T Van den Broeck, RC Van Den Bergh, N Arfi, T Gross, L Moris, E Briers, ... European urology 75 (6), 967-987, 2019 | 397 | 2019 |
| What is the negative predictive value of multiparametric magnetic resonance imaging in excluding prostate cancer at biopsy? A systematic review and meta-analysis from the … PC Moldovan, T Van den Broeck, R Sylvester, L Marconi, J Bellmunt, ... European urology 72 (2), 250-266, 2017 | 384 | 2017 |
| Intraoperative laparoscopic fluorescence guidance to the sentinel lymph node in prostate cancer patients: clinical proof of concept of an integrated functional imaging approach … HG van der Poel, T Buckle, OR Brouwer, RAV Olmos, FWB van Leeuwen European urology 60 (4), 826-833, 2011 | 372 | 2011 |
| EAU–ESTRO–ESUR–SIOG guidelines on prostate cancer N Mottet, J Bellmunt, E Briers, M Bolla, L Bourke, P Cornford, M De Santis, ... European Association of Urology, 2018 | 366 | 2018 |
| Urinary diversions after cystectomy: the association of clinical factors, complications and functional results of four different diversions JA Nieuwenhuijzen, RR de Vries, A Bex, HG van der Poel, W Meinhardt, ... European urology 53 (4), 834-844, 2008 | 361 | 2008 |
| Best practices in robot-assisted radical prostatectomy: recommendations of the Pasadena Consensus Panel F Montorsi, TG Wilson, RC Rosen, TE Ahlering, W Artibani, PR Carroll, ... European urology 62 (3), 368-381, 2012 | 345 | 2012 |
| Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised … AR Azzouzi, S Vincendeau, E Barret, A Cicco, F Kleinclauss, ... The Lancet Oncology 18 (2), 181-191, 2017 | 338 | 2017 |
| Preoperative ipilimumab plus nivolumab in locoregionally advanced urothelial cancer: the NABUCCO trial N van Dijk, A Gil-Jimenez, K Silina, K Hendricksen, LA Smit, JM de Feijter, ... Nature medicine 26 (12), 1839-1844, 2020 | 289 | 2020 |
| Metastasectomy in renal cell carcinoma: a multicenter retrospective analysis HG van der Poel, JA Roukema, S Horenblas, AN van Geel, ... European urology 35 (3), 197-203, 1999 | 283 | 1999 |
| Quality of life outcomes after primary treatment for clinically localised prostate cancer: a systematic review M Lardas, M Liew, RC van den Bergh, M De Santis, J Bellmunt, ... European urology 72 (6), 869-885, 2017 | 259 | 2017 |
